Diazepam |
![]() Last updated: 10/09/2025 |
![]() |
(Also known as: methyl diazepinone; diacepin) |
|
![]() |
|
A veterinary drugs used for its antianxiety, muscle relaxant and hypnotic properties | |
---|---|---|
|
Has a variety of applications including use as an appetite stimulant and to control seizures | |
|
Cats; Dogs |
Approval status |
|
Not approved | |
---|---|---|
|
Not approved |
Chemical structure |
|
None | |
---|---|---|
|
C₁₆H₁₃ClN₂O | |
|
CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3 | |
|
No data | |
|
AAOVKJBEBIDNHE-UHFFFAOYSA-N | |
|
InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3 | |
|
Yes |
|
![]() |
Common Name | Relationship | Link |
---|---|---|
diazepam | - | ![]() |
General status |
|
Medicinal drug: sedative | |
---|---|---|
|
Benzodiazepine | |
|
- | |
|
- | |
|
Synthetic | |
|
A positive allosteric modulators of the GABA type A receptors (GABAA). | |
|
[Gamma-aminobutyric acid receptor subunit alpha-1, Potentiator], [Gamma-aminobutyric acid receptor subunit alpha-2, Potentiator], [Gamma-aminobutyric acid receptor subunit alpha-3, Potentiator], [Gamma-aminobutyric acid receptor subunit alpha-5, Potentiator] | |
|
439-14-5 | |
|
207-122-5 | |
|
- | |
|
- | |
|
- | |
|
Anxiolytics: Benzodiazepine derivatives | |
|
QN05BA01 | |
|
UK: Class C, Schedule 4 Pt1; EU: UN71, Class IV | |
|
- | |
|
284.76 | |
|
7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one | |
|
7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one | |
|
7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one | |
|
- | |
|
- | |
|
- | |
|
White to yellow coloured crystalline powder |
Commercial |
|
|
|||
---|---|---|---|---|
|
Current | |||
|
1959, first synthesised; 1960, first approval for use in humans | |||
|
|
|||
|
|
|||
|
Supplied in both solid and liquid forms for veterinary use including injectable solution for intravenous administration | |||
|
Diazepam is synthesised through a multi-step process that begins with 5-chloro-2-(methylamino)benzophenone as the key starting material. The first major step involves N-acylation, where this compound reacts with chloroacetyl chloride to introduce an acyl group. This intermediate then undergoes a cyclisation reaction, forming the characteristic benzodiazepine ring system through intramolecular nucleophilic substitution. The resulting diazepam base is purified and subsequently converted into its hydrochloride salt for pharmaceutical use. Modern methods often employ continuous flow synthesis, which improves reaction efficiency, purity, and scalability. | |||
|
Published GHG data is not available for most pharmaceuticals. However, according to industry, global averages suggest producing 1 kg of a typical active pharmaceutical ingredient can range from 10 to 100 kg CO₂e for small molecule drugs and potentially up to 1000 kg CO₂e for complex biologicals such as vaccines, depending on the drug type, its formulation, complexity of synthesis, solvent recovery, and energy sources used. |
|
![]() |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
50 | V3 V = ChemID Online Databases; Chemspider; PubChem. (ChemID ) at 25 °C3 = Unverified data of known source |
Moderate | ||||||||
|
500000 | P3 P = Other non-EU, UK or US Governments and Regulators Chloroform3 = Unverified data of known source |
- | ||||||||
25.6 | P3 P = Other non-EU, UK or US Governments and Regulators Ether3 = Unverified data of known source |
- | |||||||||
62500 | P3 P = Other non-EU, UK or US Governments and Regulators Methanol3 = Unverified data of known source |
- | |||||||||
|
131.5 | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
- | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
3.4 | V3 V = ChemID Online Databases; Chemspider; PubChem. (ChemID ) 3 = Unverified data of known source |
- | ||||||||
- | |||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- |
Degradation |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
As this parameter is not normally measured directly, a surrogate measure is used: ‘Photochemical oxidative DT₅₀’. Where data is available, this can be found in the Fate Indices section below. | ||||||||||
|
- |
Soil adsorption and mobility |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
- | ||||||||||
|
- |
Fate indices |
|
|
|
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||||||||||||||||||||
|
|
- | - | - | |||||||||||||||||||||||||
|
- | - |
Known soil and groundwater metabolites |
None
Other known metabolites |
|
|
|
|
||||
---|---|---|---|---|---|---|---|
oxazepam | - | Humans; Animals | - | ||||
desmethyldiazepam Note: Main active metabolite |
- | Humans; Animals | - | ||||
temazepam | - | Humans; Animals | - |
|
![]() |
Terrestrial ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
249 | P4 P = Other non-EU, UK or US Governments and Regulators Rat4 = Verified data |
Moderate | ||||||||
|
|
- | - | - | |||||||
|
- | - | |||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
- | |||||||||||
|
- | - | - | ||||||||
- | |||||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - |
Aquatic ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
> 12.6 | F3 F = U.S. EPA ECOTOX database / U.S. EPA pesticide fate database / Miscellaneous WHO documents / FAO data, IPCS INCHEM data (US EPA Databases Related to Pesticide Risk Assessment ) Gambusia holbrooki3 = Unverified data of known source |
Moderate | ||||||||
|
72.0 | F4 F = U.S. EPA ECOTOX database / U.S. EPA pesticide fate database / Miscellaneous WHO documents / FAO data, IPCS INCHEM data (US EPA Databases Related to Pesticide Risk Assessment ) Danio rerio 14 day4 = Verified data |
Low | ||||||||
|
- | - | - | ||||||||
|
0.05 | F3 F = U.S. EPA ECOTOX database / U.S. EPA pesticide fate database / Miscellaneous WHO documents / FAO data, IPCS INCHEM data (US EPA Databases Related to Pesticide Risk Assessment ) Daphnia magna as mol/L3 = Unverified data of known source |
High | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
> 12.0 | F4 F = U.S. EPA ECOTOX database / U.S. EPA pesticide fate database / Miscellaneous WHO documents / FAO data, IPCS INCHEM data (US EPA Databases Related to Pesticide Risk Assessment ) Artemia parthenogenetica4 = Verified data |
Moderate | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - |
|
- | - | - | |||
|
- | - | - |
|
![]() |
General |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
249 | P4 P = Other non-EU, UK or US Governments and Regulators Rat4 = Verified data |
Moderate | ||||||||
|
800 | P4 P = Other non-EU, UK or US Governments and Regulators Rat4 = Verified data |
- | ||||||||
|
- | - | - | ||||||||
|
Intraperitoneal LD₅₀ = 37.0 mg kg⁻¹ | V3 V = ChemID Online Databases; Chemspider; PubChem. (ChemID ) Mouse3 = Unverified data of known source |
- | ||||||||
Intravenous LD₅₀ = 25.0 mg kg⁻¹ | V3 V = ChemID Online Databases; Chemspider; PubChem. (ChemID ) Mouse3 = Unverified data of known source |
- | |||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | |||||||||
|
- | ||||||||||
|
Hepatic metabolism via Cytochrome P450 enzyme system, excreted mainly in the urine | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
- |
Health issues |
|
|
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CNS toxicant May cause dermatitis Lung sensitiser Possible teratogenic effects |
Handling issues |
|
|
|||
---|---|---|---|---|
|
Will release toxic gases if heated to decomposition Not compatible with oxidising agents or strong alkalis IMDG Transport Hazard Class 6.1 |
|||
|
Health: H301, H311 | |||
|
Not listed (Not listed) | |||
|
UN2811 | |||
|
Packaging Group III (minor danger) | |||
|
- |
|
![]() |
|
|
||
---|---|---|---|
|
diazepam | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- |
Record last updated: | 10/09/2025 |
Contact: | aeru@herts.ac.uk |
Please cite as: | Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal, 22(4), 1050-1064. DOI: 10.1080/10807039.2015.1133242 |